Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q3 EPS of ($1.31), $0.08 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.